Selective dopamine-1 agonist therapy in severe hypertension: Effects of intravenous fenoldopam
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 11 (5), 1118-1123
- https://doi.org/10.1016/s0735-1097(98)90073-0
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1‐receptor agonist, in hypertensive patients.British Journal of Clinical Pharmacology, 1988
- Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.Circulation, 1987
- Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension.Journal of Clinical Investigation, 1984
- Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension.Circulation, 1984
- Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertensionThe American Journal of Cardiology, 1983
- Increased plasma norepinephrine accompanies persistent tachycardia after hydralazine.Hypertension, 1983
- Hemodynamic and natriuretic responses to intravenous infusion of dopamine in patients with essential hypertension.Japanese Circulation Journal, 1982
- Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings.Circulation, 1981
- II. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in manLife Sciences, 1981
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978